Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Glutathione

Gamma-Glu-Cys-Gly Master Antioxidant Tripeptide

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

Glutathione is an endogenous tripeptide, but the evidence for its MARKETED uses is preliminary and inconsistent, so the prior grade 4 is inflated. Oral supplementation shows a modest melanin-index reduction across roughly five small RCTs that a 2020 systematic review (Sonthalia/Dilokthornsakul) and the 2025 Sarkar review in Int J Dermatol judged inconclusive due to study quality, and liver data rest on an open-label single-arm NAFLD pilot (n=34, ALT decreased) plus a small cirrhosis RCT. The IV skin-whitening and detox uses that drive clinic demand have no supporting clinical trials and carry documented serious-harm signals, which anchors the honest grade at 2.

FDA
No FDA-approved drug for skin whitening, detox, or anti-aging by any route. Oral glutathione is sold as a dietary supplement. Injectable/IV glutathione for cosmetic skin lightening is unapproved; the US FDA issued 2019 warnings against compounding it into sterile injectables after endotoxin-linked adverse events, and it holds only narrow investigational/adjunct clinical roles.
WADA
Not on the WADA Prohibited List

Reference only. Not medical advice.

What can go wrong

IV cosmetic use is unapproved and carries anaphylaxis, endotoxin reactions, and Stevens-Johnson syndrome / toxic epidermal necrolysis signals; oral form is poorly and debatably absorbed.

Talk to a clinician before taking this. The Atlas can tell you what has been studied about Glutathione. It cannot tell you how it would interact with your body, your history, or anything else you are taking, and nothing on this page is a reason to start.

An endogenous master antioxidant tripeptide (gamma-Glu-Cys-Gly) present in every cell, whose levels decline with age. Oral bioavailability of the intact molecule is poor and debated. Small oral RCTs suggest a modest, inconsistent skin-brightening effect, and pilot liver data are preliminary. The IV 'skin-whitening' and detox use marketed by wellness clinics is unapproved and is the subject of US and Philippine FDA safety warnings, including reports of Stevens-Johnson syndrome and anaphylaxis.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Antioxidant / oxidative-stress reduction
  • Liver support
  • Skin brightening (IV)

How it is supposed to work

Glutathione is the body’s master antioxidant, a small molecule your cells make to neutralize the free radicals and oxidative stress that come with normal metabolism, and to support detoxification and the immune system. The wellness-market pitch builds on a second, narrower property: in the lab, glutathione can interfere with tyrosinase, the enzyme that makes the dark pigment melanin, and nudge pigment production toward lighter forms. That is the basis for selling it as a skin-lightening or brightening treatment, usually as an IV drip on the theory that injecting it raises body levels more than pills or creams.

Glutathione is a tripeptide, three amino acids (glutamate, cysteine and glycine) joined into a small molecule the body produces naturally. It is sold as oral supplements, topical creams and injectable or IV forms, and it is the injectable form that is most heavily marketed for cosmetic skin-lightening.

Type
Master antioxidant tripeptide
Cosmetic claim
Skin lightening
Forms
Oral, topical, IV
IV skin evidence
Weak
IV safety
Serious concerns
Cosmetic approval
None

Real Antioxidant, Unproven (And Risky) IV Drip

Glutathione itself is genuine and important: a central antioxidant with legitimate supportive medical uses in some conditions and alongside chemotherapy. The problem is the gap between that and how it is sold. For skin-lightening, the evidence is thin and uneven: oral glutathione shows modest, variable reductions in melanin and topical forms some local effect, but the heavily-promoted intravenous form has weak-to-absent evidence, with reviews noting a lack of human clinical trials, no established dosing, and leading dermatology bodies cautioning against it for cosmetic use. And the IV form carries real risks: it has been linked to serious reactions including anaphylaxis, liver and kidney injury, and severe skin reactions, and regulators have warned about contaminated compounded injectables. So the most-marketed and most-expensive way to take it is the least supported and the most dangerous.

Safety in detail

Foreground for readers: the IV 'skin-whitening' and 'detox' clinic use is the highest-risk and least-supported application. The US FDA warned in 2019 against compounding glutathione into sterile injectables after seven patients had reactions (one hospitalized) linked to endotoxin-contaminated product, and the Philippine FDA Advisory No. 2019-182 states that its unapproved use for skin lightening at very high doses is unsafe, citing thyroid, liver, kidney and nervous-system toxicity plus Stevens-Johnson syndrome and toxic epidermal necrolysis. No published clinical trial establishes IV efficacy for skin whitening.

  • Oral and topical forms are relatively low-risk, with modest effects.
  • The injectable and IV forms are the concern, linked to anaphylaxis, liver and kidney injury and Stevens-Johnson syndrome.
  • There is no standardized dosing for cosmetic IV use.
  • Regulators warned about supplement-grade glutathione being turned into sterile injectables, citing endotoxin contamination.
  • The cosmetic skin-whitening use is unapproved and cautioned against by dermatology bodies.

Children and teenagers

Glutathione has no pediatric cosmetic use; the IV skin-whitening application is unapproved and risky for anyone and has no place in minors. The skin-whitening practice itself raises real wellbeing concerns, particularly the pressure it places on young people, and any genuine antioxidant or medical need in a child belongs with a physician. There is no appropriate pediatric cosmetic use.

What people get wrong

Nothing recorded here yet. There is almost certainly something people get wrong about this one, and the blank space means we have not written it down, not that the record is clean.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Glutathione’s wellness economy runs through medical spas and IV-drip clinics selling infusions for whitening, anti-aging and detox at a premium, the large skin-whitening cosmetic market, especially in parts of Asia, and supplement makers offering oral and topical forms. The commercial engine is a real antioxidant repackaged as an expensive cosmetic injectable whose marketed benefit the evidence does not support.

How we got here

Glutathione was first isolated in the late nineteenth century and its structure as the tripeptide gamma-glutamyl-cysteinyl-glycine was established by Frederick Gowland Hopkins and colleagues in the 1920s, giving it a place among the earliest characterized biological antioxidants. Because it is endogenous rather than proprietary, it has no single owner and reaches the market under many forms: nutraceutical oral capsules and branded fermented raw materials such as Setria, and injectable products such as Tationil that were originally registered as an adjunct in cisplatin chemotherapy. The cosmetic skin-whitening use grew as an off-label repurposing of those injectables, spreading through wellness clinics and spas mainly across Southeast and East Asia, which is what prompted the 2019 regulatory safety actions rather than any approval of the cosmetic indication.

Glutathione has long been characterized as the body’s master antioxidant and studied as supportive therapy in some conditions. Its ability to interfere with melanin production drew cosmetic interest, leading first to oral and topical skin-whitening products and then to an intravenous-drip skin-whitening boom, especially in parts of Asia and later the broader wellness market, amplified by social media. Regulators and dermatology bodies issued cautions about the IV cosmetic use and contaminated injectables, yet its popularity has persisted despite weak evidence and serious risks.

  1. decadesGlutathione is established as a central endogenous antioxidant.
  2. 2000s-2010sSkin-lightening interest drives oral, topical and then IV cosmetic products.
  3. 2010sAn IV-drip skin-whitening boom spreads through wellness markets and social media.
  4. ongoingRegulators and dermatology bodies caution against cosmetic IV use and flag contamination.
  5. 2026It remains widely marketed despite weak evidence and real safety concerns.

The numbers behind the grade

Type
Antioxidant tripeptide
Cosmetic claim
Skin lightening
IV evidence
Weak
IV risks
Serious
Cosmetic approval
None
Availability
Widespread

The people taking it

A real master antioxidant heavily marketed as an IV skin-whitening, anti-aging and detox treatment, where the popular injectable use has weak evidence and serious safety risks.

Glutathione’s users center on the skin-whitening and brightening market, especially women in parts of Asia and diaspora communities, along with IV-drip wellness consumers seeking anti-aging or detox effects and antioxidant-supplement users. It draws a beauty- and wellness-clinic audience, a market with significant cultural and wellbeing dimensions.

Used as oral and topical supplements with modest skin-lightening evidence, and as heavily-marketed IV skin-whitening, anti-aging and detox drips with weak evidence and serious risk. A real antioxidant sold for an unproven cosmetic use.

Set against the alternatives

Against proven skin-lightening approaches, the contrast is stark: dermatologist treatments like topical agents, chemical peels and laser have established safety and efficacy, while IV glutathione does not. Against its own oral and topical forms, which are safer and modestly evidenced, the IV form combines weak evidence with serious risk. And within the broader IV-drip wellness trend, glutathione is one of several unproven antioxidant and detox infusions sold at a premium. The molecule is real and useful; the route being marketed is the weak link.

What we do not know

  • Whether oral or IV glutathione meaningfully and safely lightens skin over the long term, where evidence is weakest for IV.
  • How safe compounded injectable glutathione actually is, given contamination warnings.
  • Whether oral glutathione is even reliably absorbed, which is contested.
  • The wellbeing and ethical dimensions of skin-whitening marketing.

What could change

IV-drip trendThe wellness infusion trend keeps cosmetic IV glutathione popular.Regulatory cautionWarnings about contaminated injectables and unproven claims continue.Evidence gapRigorous trials are still needed to settle efficacy and dosing.Skin-whitening ethicsThe cultural and wellbeing dimensions of skin-whitening draw growing scrutiny.

The market for this

What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.

Oral and topical glutathione are widely-available supplements with modest evidence and reasonable safety. The IV skin-whitening drips are expensive, unproven for that purpose, and carry serious safety and contamination risks, so they are not advisable, and anyone seeking real skin-lightening should work with a dermatologist.

Oral and topical glutathione are inexpensive, while IV-drip clinic sessions are costly, the premium cosmetic route. The price gap reflects marketing and delivery rather than added proven benefit.

Oral and topical glutathione are broadly available, while compounded IV glutathione carries the sterility and contamination risk regulators warned about. The injectable route is the riskiest, and quality varies.

Supplement makersProduce widely-available oral and topical glutathione.Compounding pharmacies and clinicsPrepare injectable and IV glutathione, the form regulators flagged for contamination risk.Skin-whitening cosmetic marketA large industry, particularly in parts of Asia, drives demand.

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Glutathione.

Nothing outstanding on this one.

Sources

The studies that matter

  • Antioxidant biologyestablished

    Glutathione is a well-characterized endogenous antioxidant central to neutralizing oxidative stress and supporting detoxification.

  • Oral skin-lighteningsmall trials

    Oral glutathione produced modest, variable reductions in melanin, though its bioavailability is itself contested.

  • Topical glutathionelimited

    Topical forms showed some local pigment reduction and texture effect, but research is limited and sustainability varies.

  • IV skin-whiteningweak/absent

    Reviews found the efficacy of IV glutathione for skin-whitening unclear, with no human clinical trials and no established dosing.

  • Safety signalsdocumented

    IV glutathione has been linked to anaphylaxis, liver and kidney injury and severe skin reactions, and regulators warned about contaminated compounded injectables.